Atrium Therapeutics, Inc. (RNA) research

Atrium Therapeutics, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$8.33
As of

Atrium Therapeutics, Inc. (RNA): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-13.

As of . Source: SEC EDGAR filings for RNA. Method and limitations.

SHARE THIS CARD

Share the RNA intelligence card

A branded snapshot of RNA: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion RNA intelligence card preview
Post to X
LIVE TERMINAL

See RNA live in the terminal

Track RNA's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live RNA terminal, free

Active signals for RNA

FREE, NO ACCOUNT

Every signal on RNA, as it fires

You are seeing 5 of 20 signals recorded on RNA since 2026-05-17.

The five above all landed on 2026-09-06. The other 15 were recorded on 3 other days. 14 of the 20 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in RNA (2026Q2)

Manager / securityMarket value% portfolioQoQ
TWO SIGMA INVESTMENTS, LPCUSIP 04965N104 · 2026Q2$4.6M0.00%,
MILLENNIUM MANAGEMENT LLCCUSIP 04965N104 · 2026Q2$2.7M0.00%,
CITADEL ADVISORS LLCCUSIP 04965N104 · 2026Q2$910K0.00%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 04965N104 · 2026Q2$201K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, RNA

RNA mentioned in Kresmion daily briefs

Related tickers

See more RNA signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to RNAand get the insider, 13F, options, and confluence read in one view.

Open the live RNA terminal, free